OTOsamu Togao

Osamu Togao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Osamu Togao has a total of 57 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Patterns of Failure After Postoperative Radiotherapy for WHO Grade 2–3 Meningiomas: A Single-Institution Experience

    by Mitsutoshi Ooishi, Osamu Togao, Hiroshi Ito, Fumitaka Yoshioka, Tatsuya Abe

    Background/Objectives: World Health Organization (WHO) Grade 2–3 meningiomas have high recurrence rates despite postoperative radiotherapy. This study aimed to characterize patterns of failure and clinical outcomes after postoperative external beam radiotherapy. Methods: We retrospectively analyzed 10 patients with WHO Grade 2 (n = 6) or Grade 3 (n = 4) meningiomas treated at a single institution between January 2017 and May 2024. Nine patients underwent gross total resection. Radiotherapy was delivered using three-dimensional conformal radiotherapy (n = 6) or intensity-modulated radiotherapy (n = 4), with a median dose of 60 Gy in 30 fractions. Recurrence patterns were assessed relative to the high-dose region. Results: The 1- and 3-year overall survival rates were 90% (95% CI, 47–99%) and 79% (95% CI, 38–94%), respectively; corresponding local control rates were 70% (95% CI, 33–89%) and 39% (95% CI, 7–71%), respectively. Recurrence occurred in six patients, predominantly within the high-dose region. Acute toxicities were limited to Grade 1 radiation dermatitis. During follow-up, Grade 3 seizures occurred in three patients, and worsening of pre-existing Grade 2 paresis occurred in four patients. Two seizure events and two cases of worsening paresis were considered more likely related to recurrent or progressive disease, whereas attribution of the remaining neurological events to radiotherapy was uncertain. Conclusions: Despite postoperative radiotherapy, local control remained limited in this small, single-institution series, with a predominance of in-field recurrence. This pattern raises the possibility that tumor biological factors, in addition to technical and treatment-related factors, may contribute to treatment failure in WHO Grade 2–3 meningiomas. These findings are exploratory and warrant validation in larger studies incorporating molecular stratification and standardized treatment approaches.

  • A CT-based score for predicting histopathological usual interstitial pneumonia features and predicting disease progression in smokers with fibrotic idiopathic interstitial pneumonia

    by Ryoko Egashira, Kiminori Fujimoto, Kensuke Kataoka, Jun Fukihara, Daisuke Yamada, Mikiko Hashisako, Tomoyuki Fujisawa, Ken Yamaguchi, Takahiko Nakazono, Takafumi Suda, et al.

    Objectives Histopathological usual interstitial pneumonia (UIP) features are associated with progressive fibrosis but may be overlooked in smokers, where emphysema and smoking-related fibrosis complicate CT-based UIP classification. This study aimed to develop and validate a CT-based score to detect histopathological UIP features and to evaluate its association with disease progression in smokers with fibrotic idiopathic interstitial pneumonia (IIP). Materials and methods This retrospective multicentre study included two biopsy-proven cohorts of smokers with fibrotic IIP: derivation (n = 242; nationwide registry) and validation (n = 126; single-centre database, 2008–2013). Three predefined HRCT findings—upper-lobe irregular lines (U), irregularity of pleural surface (I), and pleural-based basal reticulation (P)—were scored (0/1) and summed as the U-I-P score (0–3). Associations with histopathological UIP features and outcomes were assessed using logistic regression, receiver operating characteristic analysis, Cox proportional hazards models, and bootstrap internal validation. Results Cohorts were similar (median age 65 vs. 64 years; 88% vs. 87% male). Histopathological UIP features were present in 208/242 (86%) and 109/126 (87%) patients. The U-I-P score independently predicted histopathological UIP features in both cohorts (area under the curve, 0.83 and 0.89; both p < 0.001). Bootstrap validation demonstrated minimal optimism, supporting model stability. The U-I-P score independently predicted disease progression at 1 and 2 years in the validation cohort (p = 0.002 and p = 0.001, respectively). Conclusion The U-I-P score detects histopathological UIP features and predicts disease progression in smokers with fibrotic IIP, providing a practical imaging biomarker, even in cases with atypical CT patterns. Key Points Question: In smokers with fibrotic interstitial lung disease, emphysema and smoking-related fibrosis complicate CT pattern classification, limiting identification of usual interstitial pneumonia pathology. Findings: The U-I-P (upper-lobe irregular lines, irregularity of pleural surface, pleural-based reticulation) score detected histopathological usual interstitial pneumonia features and predicted progression. Clinical relevance: The U-I-P score aids identification of smokers with usual interstitial pneumonia-type fibrosis and increased risk of progression when biopsy is unavailable, or CT patterns are atypical for usual interstitial pneumonia. Graphical Abstract

  • The diagnostic value of cortical high-flow sign combined with cystathionine on 1H-MRS for prediction of 1p/19q-codeletion status in IDH-mutant adult-type diffuse glioma

    by Koji Yamashita, Moyoko Tomiyasu, Kazufumi Kikuchi, Daichi Momosaka, Masaoki Kusunoki, Daisuke Kuga, Ryusuke Hatae, Yutaka Fujioka, Ryosuke Otsuji, Osamu Togao, et al.

    Objectives To leverage a combination of cortical high-flow sign on arterial spin labeling (ASL) and cystathionine measurement using 1H-MR spectroscopy (1H-MRS) to distinguish oligodendroglioma, IDH-mutant and 1p/19q-codeleted (O_IDHm-codel) from astrocytoma, IDH-mutant (A_IDHm-noncodel). Materials and methods We implemented pseudo-continuous ASL technique (post-labeling delay = 2000 ms) using a 3.0-T MRI scanner. Relative perfusion maps were generated by subtracting paired labeled images from control images. 1H-MRS data were acquired by using the single-voxel point-resolved spectroscopy sequence (PRESS) sequence (TR = 2000 ms, TE = 97 ms, NEX = 128, volume of interest = 203 mm3). Our study included cases with a Cramér-Rao Lower Bound of cystathionine levels at 2.7 ppm that were below 50%. The presence or absence of cortical high-flow sign and the estimated concentration of cystathionine were compared between A_IDHm-noncodel and O_IDHm-codel. The receiver operating characteristic curves were used to evaluate the diagnostic performance of each parameter, as well as the combination of both. Results The cortical high-flow sign was identified more frequent in O_IDHm-codel (7/12, 58.3%) than in A_IDHm-noncodel (3/18, 16.7%; p = 0.018). The cystathionine levels in O_IDHm-codel (1.50 ± 0.63 mM) was significantly higher than in A_IDHm-noncodel (0.85 ± 0.24 mM; p = 0.001). The area under the curve for distinguishing O_IDHm-codel from A_IDHm-noncodel using the presence of cortical high-flow sign, cystathionine levels, and their combination was 0.708 (0.509–0.908), 0.750 (0.553–0.947), and 0.875 (0.737–1.000), respectively. Conclusion The presence of cortical high-flow sign on ASL, along with elevated cystathionine levels measured by 1H-MRS, could differentiate O_IDHm-codel from A_IDHm-noncodel.


  • Time-intensity Profiles and T1-corrected Arterial Transit Time from Multi-delay Pseudo-continuous ASL with a Variable-TR Scheme for the Characterization of Adult-type Diffuse Glioma

    by Koji Yamashita, Makoto Obara, Kazufumi Kikuchi, Ryoji Mikayama, Daichi Momosaka, Masaoki Kusunoki, Daisuke Kuga, Ryusuke Hatae, Yutaka Fujioka, Ryosuke Otsuji, et al.

    Purpose The cerebral blood flow (CBF) measured by multi-delay ASL (4D-ASL) offers superior diagnostic performance compared to single-delay ASL-CBF for glioma grading. Dynamic changes in signal intensity (SI) and arterial transit time (ATT) obtained from 4D-ASL may also be key factors in differentiating adult-type diffuse glioma. Furthermore, the longitudinal relaxation time (T1) of brain tumor may influence on CBF and ATT when using ASL techniques. Our purpose was to determine if time-intensity profiles from 4D-ASL using a variable-TR scheme and T1-corrected ATT (ATTT1corr) could distinguish among adult-type diffuse gliomas. Materials and Methods The 4D-ASL with a variable-TR scheme data were collected by changing the labeling duration (LD) and post-labeling delay (PLD). Data acquisition at each phase consisted of pre-saturation and control or labeling modules followed by data acquisition. A total of 14 LD and PLD combinations were used. In addition, T1 measurement was conducted using pseudo-continuous ASL with a variable-TR scheme, without label and background suppression pulses. The SI peak time was obtained based on the time-intensity curve. The SI peak time, ATT, and ATTT1corr were compared among adult-type diffuse gliomas. Results Thirty patients were included in the study. ATT and the SI peak time in diffuse glioma with IDH-wildtype (IDHw) were significantly shorter than astrocytoma, IDH-mutant (p < 0.01, each). Moreover, ATTT1corr in astrocytoma, IDH-mutant was longer than the other types of diffuse glioma (p < 0.0001). Conclusion The 4D-ASL with a variable-TR scheme includes ATTT1corr and the SI peak time could potentially improve the differential diagnosis of adult-type diffuse gliomas.

  • Open Access

    CT findings of lung injury during breast cancer treatment

    by Ken Yamaguchi, Ryoko Egashira, Takahiko Nakazono, Yutaka Yoshinaga, Koichi Baba, Masako Kataoka, Hidetake Yabuuchi, Takatoshi Aoki, Osamu Togao

    While breast cancer treatment outcomes have improved significantly through multidisciplinary approaches including surgery, chemotherapy, and radiation therapy, the incidence of non-neoplastic pulmonary complications has also increased. Accurate interpretation of chest imaging is essential for managing these adverse events. This review outlines the major radiological findings of pulmonary injury during breast cancer treatment, focusing on two primary categories: drug-associated interstitial lung disease (DILD) and radiotherapy-associated lung injury (RLI). Regarding DILD, its clinical features, risk factors, differential diagnosis, and diverse patterns on high-resolution CT (HRCT) are described. The lung injury characteristics associated with specific drugs used in breast cancer treatment are also examined, placing particular emphasis on clinically important agents like trastuzumab deruxtecan. Regarding RLI, the pathophysiology (including acute radiation pneumonitis and chronic radiation fibrosis), relevant risk factors, and typical CT findings localized to the radiation field are discussed. Atypical manifestations are also addressed, such as radiation-induced organizing pneumonia (OP) outside the radiation field and the unique phenomenon of radiation recall pneumonitis. These complications can present with symptoms and imaging findings that mimic one another as well as other conditions, such as infections and lymphangitic carcinomatosis. This review aims to facilitate the timely and accurate differential diagnosis of pulmonary complications in breast cancer patients, thereby guiding appropriate therapeutic strategies and enhancing patient safety.